Apr 14, 2022
This week we interview Renee Ryan, CEO of Cala. Renee has 25 years of building category-creating healthcare companies. Before joining Cala as CEO in August 2019, she led Johnson & Johnson Innovation (JJDC) on the West Coast and the Asia Pacific for eight years. While at J&J, she made over 15 new investments, including the Series A for Cala Health. Previously, she was a healthcare investment banker at RW Baird, Jefferies, and Goldman Sachs. Renee currently sits on the boards of Cala, Neuropace, and RefleXion Medical.